文献速递生殖医学

标准临床条件下囊胚腔液与培养液作为胚胎植入前遗传学检测DNA来源的诊断效能

Diagnostic efficacy of blastocoel fluid and spent media as sources of DNA for preimplantation genetic testing in standard clinical conditions.
PubMed 文献 · Fertil Steril · 2018-01-01

该前瞻性盲法研究纳入26例接受胚胎植入前遗传学检测(PGT)患者的103份滋养外胚层(TE)、92份囊胚腔液(BF)和72份培养液(SBM)样本,评估BF与SBM作为DNA模板的诊断效能。结果显示BF与SBM与TE诊断一致率低(单基因病检测中BF 2.9%、SBM 20.8%),BF在非整倍体检测中扩增失败率高达65.2%,一致率仅37.5%。作者结论认为基于当前方法BF与SBM的遗传分析结果不够可靠,不足以临床常规使用。

要点

  • 单基因病检测中BF与TE诊断一致率仅2.9%(2/69),SBM为20.8%(15/72)。
  • SBM相比BF有更高不一致率和更高伪影/污染检出,且检出母源突变DNA持续存在。
  • 非整倍体检测中BF扩增失败率65.2%,扩增样本总体一致率37.5%。

核心结论

  • 基于当前方法,BF与SBM的遗传分析结果不够可靠,不足以在临床中应用。
  • 在无法妥善防止母源污染风险之前,SBM不应被用于PGT-M目的。

研究设计与样本

  • 前瞻性盲法研究,在遗传实验室进行。
  • 纳入26例接受PGT治疗的患者,共103份TE、92份BF和72份SBM样本。
  • BF与SBM在TE活检时获取,采用两种DNA提取策略在独立BF和SBM样本上评估。
  • 后续样本使用下一代测序和定量聚合酶链反应进行单基因病(PGT-M)或非整倍体(PGT-A)评估。

主要发现

  • 所测试的DNA提取方法之间未检测到差异。
  • PGT-M检测中,BF样本与对应TE诊断一致的比例为2.9%(2/69),SBM为20.8%(15/72)。
  • SBM相比BF与更高不一致率和更高伪影/污染检出相关。
  • 多次在纯合野生型胚胎的SBM中检出母源突变变异,显示培养液中母源DNA持续存在。
  • PGT-A检测中,BF分析显示高扩增失败率(65.2%),扩增样本总体一致率为37.5%。

临床怎么用

  • 原文结论认为BF与SBM的遗传分析结果不够可靠,不足以临床使用。
  • 原文结论指出在无法妥善防止母源污染风险之前,SBM不应被用于PGT-M目的。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether blastocoel fluid (BF) or spent blastocyst medium (SBM) is a suitable template for genotype and/or karyotype assessment of in vitro fertilization-generated embryos. DESIGN: Prospective blinded study. SETTING: Genetic laboratory. PATIENT(S): From 26 patients undergoing preimplantation genetic testing (PGT) treatments, 103 trophectoderms (TE), 92 BF samples, and 72 SBM samples. INTERVENTION(S): The BF and SBM were retrieved at the time of TE biopsy. Two DNA extraction strategies were evaluated on independent BF and SBM samples. Further enrolled samples were processed using next-generation sequencing and quantitative polymerase chain reaction for assessment of monogenic disorders (PGT-M) or aneuploidy (PGT-A). MAIN OUTCOME MEASURE(S): DNA amplification and concordance rates across BF, SBM, and TE to assess diagnostic efficiency. RESULT(S): No differences were detected among the DNA extraction methods tested. In PGT-M tests, for BF and SBM, 2.9% and 20.8% of all samples, respectively, produced a diagnosis concordant with the corresponding TE (n = 2 of 69 and 15 of 72, respectively). The SBM samples were associated with higher discordance rates and higher artifacts/contamination detection compared with BF. In multiple occasions, the maternal mutated variant was detected in the SBM of homozygous wild-type embryos, showing evidence of maternal DNA persistence in culture medium. In PGT-A tests, BF analysis showed high amplification failure rates (65.2%) and an overall concordance rate of 37.5% among amplified samples. CONCLUSION(S): Based on current methodologies, BF and SBM genetic analyses do not provide sufficiently reliable results to be employed clinically. Until the risk of maternal contamination can be properly prevented, SBM should not be used for PGT-M purposes.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Capalbo A, Romanelli V, Patassini C, et al. Diagnostic efficacy of blastocoel fluid and spent media as sources of DNA for preimplantation genetic testing in standard clinical conditions. Fertil Steril. 2018. PMID: 30316433. doi:10.1016/j.fertnstert.2018.05.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。